Both in Pharmaceuticals
Alkermes vs Corcept Therapeutics
Over the past year ALKS returned +47.7% and CORT returned +10.4%; their daily moves had a correlation of 0.19.
ALKS +47.7% CORT +10.4%Growth of $1, one year, split-adjusted
| Metric | ALKS | CORT |
|---|---|---|
| Price | $45.34 | $81.12 |
| Market cap | $7.61B | $8.77B |
| Today | −0.07% | −5.62% |
| 1 month | +11.8% | −28.9% |
| 6 months | +35.8% | +57.8% |
| Year to date | +62.0% | +133.1% |
| 1 year | +44.2% | +12.6% |
| Revenue growth (YoY) | +27.0% | +31.7% |
| Gross margin | 80.2% | 98.4% |
| Net margin | 0.1% | 16.8% |
| P/E (TTM) | 115.0× | 160.9× |
| Price / sales | 4.6× | 10.6× |
| Net cash | -$846.5M | $308.2M |
| Dividend yield | — | — |
| Volatility (60d) | 31.7% | 59.9% |
| Short % of float | 11.5% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).